The experts who attended
Dedicated professionals committed to clinical excellence.
Meet Southern Star Research at AusBiotech 2026
Southern Star Research will be attending the AusBiotech International Conference 2026, taking place on the Gold Coast from 21–23 October 2026.
As Australia’s largest biotechnology conference, the AusBiotech International Conference brings together Australian and international biotechnology leaders, investors and industry partners to advance collaboration across research, clinical development and commercialisation.
This year, the conference will be presented alongside the AusMedtech Conference as part of Australia’s Biggest Week in Biotech.
For biotechnology companies progressing new therapies, the conference is an opportunity to explore how Australia and the broader Asia-Pacific region can support efficient, globally relevant clinical development.
Australian Expertise. Broader Asia-Pacific Reach.
Southern Star Research is an Australian-headquartered, full-service CRO combining deep knowledge of Australia’s clinical trial environment with practical delivery experience across Asia-Pacific.
Our teams understand the CTN pathway, Australian ethics requirements and the operational considerations that can influence study start-up and delivery. We work closely with sponsors to review protocols, identify potential challenges early and develop practical strategies before studies reach sites.
With direct access to senior expertise and longstanding relationships with clinical units, investigators and research sites, we support informed planning, efficient start-up and consistent clinical trial delivery.
Through our strategic partnership with Expecto Health Sciences, we extend these capabilities across Asia-Pacific, providing access to experienced teams, established site networks and local knowledge across key regional markets.
This combination of Australian expertise and wider regional reach enables sponsors to build development strategies that can begin in Australia and expand across Asia-Pacific as their programs progress.
How We Support Your Clinical Development
- Proactive Partnership: We commit to engaging intellectually and energetically with our clients’ challenges. Our teams apply foresight, critical thinking and domain expertise to anticipate obstacles and contribute meaningfully to the trial’s success.
- Embedded Quality: We define quality not just by compliance, but by the consistent application of judgment, rigour and thoughtful planning throughout all stages of the clinical trial process.
- Tailored Execution: Our flexible, hands-on approach means your study is designed for both scientific and commercial success, tailored to your strategy, timelines and endpoints.
As a mid-sized CRO with strong early-phase capabilities, Southern Star Research supports first-in-human, first-in-patient and Phase I–II clinical trials, as well as later-phase development.
Our focus is on generating high-quality data that meets international regulatory expectations and supports confident decisions as programs progress towards later-stage development, partnerships, licensing and future investment.
Meet Our Team at AusBiotech 2026
Attending AusBiotech 2026?
Connect with Joe Cox, Business Development Manager, Harry Bennett, Business Development Manager, and Diana Lucia, Clinical Strategy & Bid Manager who will be representing Southern Star Research throughout the conference.
Whether you are planning your first clinical trial in Australia, considering expansion across Asia-Pacific or looking for a CRO partner for your next stage of development, we would welcome the opportunity to learn more about your program.
Contact us to arrange a meeting with the Southern Star Research team at AusBiotech 2026.